Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2017; 7(4): 149-156


Assessment of Drug Adherence Level According to the Patients’ Opinion: Results of Research in Lviv of Ukraine

Tetiana Ryvak, Khrystyna Makukh, Andriy Zimenkovsky.




Abstract

Poor adherence of chronic diseases treatment is a worldwide problem, in Ukraine as well. Improving adherence also enhances patients’ safety. Consequently, interventions that target adherence must be tailored to the particular illness-related demands experienced by the patient. The aim of the research was to determine the patient’s adherence level to pharmacotherapy through «face-to-face» interview 55 patients (visitors) in a pharmacy in Lviv (Ukraine). The methods of descriptive statistics have been used during the research results’ analyzes. The main 3 categories of factors of non-adherence to pharmacotherapy in Ukraine were conducted: 1) factors related to the patient (59.7%); 2) factors related with pharmacotherapy (26.9%); 3) socio-economic factors (13.4%). We established that the most common problems of non-adherence were: missed drugs dosage’s (40.1%), contravention duration pharmacotherapy (32.9%) and contravention of frequency of taking medicines (14.6%). We established that the level of adherence declines with the increase of number prescribed drugs (r=-0.33; R=-0.35; p

Key words: Drug adherence level, «face-to-face» interview, non-adherence factors, pharmacotherapy.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.